NasdaqGS - Delayed Quote USD
Indivior PLC (INDV)
13.89
-0.04
(-0.29%)
At close: 4:00:01 PM EDT
13.89
0.00
(0.00%)
After hours: 4:35:53 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 5 | 6 |
Avg. Estimate | 0.24 | 0.25 | 1.2 | 1.36 |
Low Estimate | 0.22 | 0.25 | 1.13 | 1.23 |
High Estimate | 0.27 | 0.26 | 1.36 | 1.54 |
Year Ago EPS | 0.44 | 0.54 | 1.66 | 1.2 |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 7 | 7 |
Avg. Estimate | 239.43M | 246.3M | 1.03B | 1.06B |
Low Estimate | 238.5M | 245M | 998.8M | 1.02B |
High Estimate | 240M | 247M | 1.13B | 1.12B |
Year Ago Sales | 299M | 307M | 1.19B | 1.03B |
Sales Growth (year/est) | -19.92% | -19.77% | -13.15% | 2.94% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | 0.4 | 0.41 | 0.26 | 0.23 |
EPS Actual | 0.44 | 0.54 | 0.32 | 0.41 |
Difference | 0.04 | 0.13 | 0.06 | 0.18 |
Surprise % | 9.09% | 32.79% | 22.65% | 75.72% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.24 | 0.25 | 1.2 | 1.36 |
7 Days Ago | 0.24 | 0.25 | 1.2 | 1.36 |
30 Days Ago | 0.24 | 0.25 | 1.2 | 1.36 |
60 Days Ago | 0.26 | 0.27 | 1.13 | 1.38 |
90 Days Ago | 0.26 | 0.27 | 1.13 | 1.42 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | 1 | 3 | 1 |
Up Last 30 Days | -- | 1 | 3 | 1 |
Down Last 7 Days | 1 | 2 | 2 | 4 |
Down Last 30 Days | 1 | 2 | 2 | 4 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
INDV | -45.45% | -53.09% | -27.69% | 13.31% |
S&P 500 | 13.13% | 2.43% | 7.54% | 14.06% |
Upgrades & Downgrades
Maintains | Piper Sandler: Overweight to Overweight | 3/6/2025 |
Reiterates | Piper Sandler: Overweight to Overweight | 10/25/2024 |
Maintains | Craig-Hallum: Buy to Buy | 10/11/2024 |
Reiterates | Piper Sandler: Overweight to Overweight | 10/11/2024 |
Reiterates | Piper Sandler: Overweight to Overweight | 9/13/2024 |
Initiated | Piper Sandler: Overweight | 7/23/2024 |
Related Tickers
TSND.TO TerrAscend Corp.
0.3300
-5.71%
LFCR Lifecore Biomedical, Inc.
6.73
-1.46%
ANIK Anika Therapeutics, Inc.
10.93
-3.02%
CPIX Cumberland Pharmaceuticals Inc.
5.24
-10.58%
SUPN Supernus Pharmaceuticals, Inc.
32.03
-2.26%
COLL Collegium Pharmaceutical, Inc.
29.18
-1.42%
KMDA Kamada Ltd.
6.88
-0.86%
DERM Journey Medical Corporation
6.78
-2.73%
NDOI Endo, Inc.
20.90
-1.65%
6785.TWO Alar Pharmaceuticals Inc.
141.00
-0.70%